MRNA

Moderna, Inc. is a biotechnology company that develops messenger RNA (mRNA) medicines, using its platform to design, formulate and manufacture mRNA‑based vaccines and therapeutics that instruct cells to produce target proteins. It operates primarily in the healthcare sector, focusing on infectious‑disease vaccines, oncology, rare‑disease and other therapeutic areas. The firm gained global prominence by rapidly bringing its COVID‑19 vaccine, Spikevax, to market and has since expanded its pipeline to include products such as an RSV vaccine, flu candidates and personalized cancer treatments, positioning it as a leading player in the emerging mRNA therapeutics space.